Transcript Highlights:

• This afternoon, I'll be giving a brief overview of the 340B drug pricing program.
• So, what is the 340B drug pricing program?
• drug pricing program.
• House Bill 2145 relates to the 340B drug pricing program. Thank you.
• House Bill 2145 relates to the 340B drug pricing program.

Bills: HB2145, HB1828, HB2155, HB2437

Keywords: 340B drug pricing, healthcare access, patient rights, discounted medications, manufacturer limitations, health professions, plasma donation, physician substitutes, medical regulation, nursing titles, healthcare, regulation, professional standards, licensure, accreditation, opioid treatment, health services, fee authority, public health, 904

Summary: The committee heard staff reports, sponsor testimony, and public testimony on House Bill 2437, which would place the Department of Health’s existing opioid treatment program accreditation role into statute and authorize the department to set fees to cover the cost of administering accreditation. Supporters, including the prime sponsor and DOH, said the bill would preserve a critical service for opioid treatment programs, including many tribal providers, and help avoid reliance on third-party accreditors with more burdensome requirements. No vote was taken on the bill during the portion provided. The committee then held an extended work session on the 340B drug pricing program and later opened public testimony on House Bill 2145, which would prohibit manufacturers, distributors, and third-party logistics providers from restricting 340B drug acquisition or delivery and from conditioning access on claims or utilization data. Staff and outside presenters explained how 340B works, recent litigation over contract pharmacy restrictions, and state trends in 340B-related legislation. Testimony was sharply divided: hospitals, community health centers, tribal representatives, labor groups, and some pharmacies argued the bill protects safety-net care, rural access, and patient services funded by 340B savings; manufacturers, employer groups, and business associations argued the program has grown far beyond its original purpose, lacks transparency, increases costs for employers and taxpayers, and should be reformed federally instead. No action was taken on HB 2145 in the excerpt. Finally, the committee began House Bill 2155, which would bar non-human entities from using nursing titles such as nurse, RN, LPN, or advanced registered nurse practitioner. The prime sponsor and the Washington State Nurses Association said the bill is intended to protect patient safety, transparency, and the integrity of the nursing profession as AI tools become more common in health care. A committee member asked about enforcement and liability if an AI system misrepresented itself as a nurse, and staff said they would follow up with more information. Public testimony on HB 2155 had just begun when the excerpt ended.

Transcript Highlights:

• . >> Senator Figures, Senator Hatcher, Senator Hovy, Senator Kitchens, Senator Price, Senator Shelnutt
• Senator Hatcher. >> Senator Hovy. >> Senator Kitchens. >> Aye. >> Senator Price. >> Aye. >> Senator Shelnutt
• Senator Price seconds. Any objection to using the previous roll?" >> Seeing none.
• Senator Price seconds. Okay. Add Senator Stutts to the roll, if you will, please.
• . >> Senator Figures. >> Senator Hatcher. >> Senator Hovy, hi. >> Senator Kitchens, hi. >> Senator Price

Bills: SB209, SB248, HB122, SB99, SB209, SB248, HB122, SB99

Keywords: sales tax exemption, Consumer Price Index, local government, clothing, school supplies, emergency preparedness, Alabama Administrative Procedure Act, APA, administrative law, judicial review, agency deference, Chevron deference, de novo review, contested case, state agency, regulatory power, individual liberty, statutory interpretation, rule interpretation, license revocation

Transcript Highlights:

• drug pricing program.
• As background, the 340B drug pricing program requires drug manufacturers to provide price discounts on
• A 340B medication is reimbursed at the same rate, and in fact, 340B helps discourage excessive drug prices
• And in fact, 340B helps discourage excessive drug prices when a manufacturer raises their price faster
• When manufacturers chip away at 340B, they're not just affecting drug prices.

Bills: SB5904, SB5915, SB6025, SB5933, SB5990, SB5981

Keywords: nursing titles, licensure, healthcare professionals, patient safety, professional standards, SB 5915, health technology assessment, HTA, clinical committee, medical technology review, coverage determination, state-purchased health care, Washington health care, RCW, evidence-based medicine, cost-effectiveness, safety and efficacy, Medicare coverage, national coverage determination, clinical guidelines

Summary: The Senate Health and Long-Term Care Committee held public hearings on several bills. SB 5904 would clarify that only human beings may use nursing titles, including in the context of AI or chatbots; the sponsor and nursing witnesses said it would protect transparency, patient safety, and the nursing profession, and testimony was overwhelmingly supportive. SB 5915 would change the Health Technology Assessment Program’s review criteria and timelines, giving priority to technologies already recommended by Medicare or national guidelines; supporters, including educators and patients with rare or serious conditions, said the current process is too rigid and can block access to needed treatments. SB 6025 would update the definition of fetal death to use the best clinically accurate gestational age rather than last menstrual period; the sponsor and clinicians said this would align the law with medical practice and reduce emotional and financial burdens on grieving families, though the hearing drew substantial opposition sign-ins. SB 5933 would require the Department of Health to share EMS overdose data in near real time with ODMAP, with privacy protections and limits on law-enforcement use; public health, local government, recovery, and youth witnesses said it would improve overdose response and save lives, while the Poison Center asked for amendments to include its data and avoid conflating overdoses with poisonings. SB 5990 would allow APRNs or physician assistants to serve as local health officers in counties under 100,000 population; the sponsor said rural counties need more flexibility, while local public health groups supported broader access but raised concerns about qualifications, and naturopathic physicians argued they should also be included. SB 5981 would prohibit drug manufacturers from limiting 340B drug access through contract pharmacies or requiring extra data as a condition of sale; safety-net hospitals, health centers, rural providers, and patients said it protects access and funds care, while manufacturers, employer groups, and some industry representatives argued the program lacks transparency, can raise costs, and should be narrowed. No final votes were taken in the excerpt, and the committee closed each hearing after testimony, with sign-in counts noted for several bills.

Transcript Highlights:

• And at the mercy of drug companies that can keep prices high by blocking competition and abusing the
• But they try to accomplish the same thing of making PBMs operation in the pricing of our drugs more transparent
• It leads to higher drug prices for patients, and I appreciate Senator Blumenthal for working with me
• I look forward to continuing all of our efforts to address the problems of high drug prices for Texans
• The fact is drug prices are too high.

Bills: SB1040, SB1041, SB1095, SB1096, SB1097, SB527

Keywords: drug competition, product hopping, generic drugs, biosimilars, federal regulations, FTC Act, patent, biological products, healthcare access, affordable prescriptions, Medicare, Federal Trade Commission, sham petitions, competition, public health, unfair competition, healthcare, pharmaceutical, antitrust law, pay-for-delay

Summary: The meeting focused on addressing the high cost of prescription drugs and the abusive practices that contribute to elevated prices affecting American families. Several bills were presented, including proposals to end pay-for-delay deals and to enhance transparency in the operations of pharmacy benefit managers (PBMs). The discussion was notable for its emphasis on consumer protection and ensuring that cheaper generic drugs reach the market more effectively. Members expressed frustration over past attempts to pass similar legislation stalling in the Senate, leading to renewed efforts to push these bills forward.

Bills: SB96, SB97, SB130, HB230, SB154, SB93, SB99, SB96, SB97, SB130, HB230, SB154, SB93, SB99

Keywords: salvage title, salvage certificate of title, rebuilt title, flood vehicle, junk vehicle, total loss, motor vehicle title, vehicle branding, insurance claim, insurance company, Department of Revenue, vehicle inspection, rebuilder, automotive dismantler, parts recycler, secondary metals recycler, junkyard, vehicle identification number, VIN, stolen vehicle

Transcript Highlights:

• drug pricing program.
• of Health, including drug cost payment amounts received for 340B drugs, payments made to pharmacies
• and other entities, and how the covered entity uses 340B drug savings.
• drug price transparency program to be publicly disclosed and requires the Health Care Authority to include
• drug pricing program, before us.

Bills: SB5921, SB5185, SB6182, SB6115, SB6258, SB5916, SB5981, SB5985, SB6019, SB6161, SB6183

Keywords: psilocybin, mental health, therapy, decriminalization, legalization, international medical graduates, preceptorship, hardship pathways, medical practice, licensure, abortion, reproductive health, pregnancy termination, clinic access, abortion access fund, abortion savings account, health carrier assessment, insurance assessment, health insurer tax, Department of Health

Summary: The Senate Health and Long-Term Care Committee held public hearings on several bills, with most of the discussion centered on Senate Bill 5921, which would create a Department of Health medical psilocybin program for adults with qualifying conditions. The staff briefing described licensing for producers and participating clinicians, training and safety standards, data collection, and a 2028 effective date. Senator Jesse Solomon said the bill uses a medical-control model and is intended to provide supervised access for conditions such as treatment-resistant depression and PTSD. Testimony was sharply divided: supporters included clinicians, veterans, first responders, and patients who described personal benefit and argued the bill would create a safe, regulated pathway; opponents and some medical groups raised concerns about missing safeguards, contraindications, monitoring, cost, and the bill’s exclusion of broader decriminalization or community-use protections. The hearing closed with 25 people signed in pro, 140 con, and 7 other. The committee also heard Senate Bill 5185, a pilot program to create a pathway for international medical graduates with clinical experience licenses to obtain full unrestricted primary care licensure. Senator Rebecca Saldana and supporters from the Washington State Medical Association, the Washington Medical Commission, and the International Medical Graduate Academy said the bill builds on an existing pathway, improves access to care, and maintains patient safety standards. No opposition testimony was presented, and the hearing closed with 9 pro and 118 con sign-ins. In executive session, the committee advanced several bills with amendments or substitutes: SB 5916 on non-opioid pain drugs, SB 5981 on 340B drug pricing transparency, SB 5985 on endometriosis resources, SB 6019 on home care rate statutes, SB 6161 on Department of Health dementia information, and SB 6183 on HIV antiviral drug coverage. The committee adopted proposed substitutes or amendments and sent the bills onward, with some referred to Rules and others to Ways and Means. The committee later reopened and completed the hearing on Senate Bill 6115, which would fund a comprehensive cancer education program for students in grades 6 through 12. Supporters, including Cancer Pathways staff, educators, and families affected by cancer, said early education could reduce risk behaviors like vaping and improve prevention; the hearing closed with 33 pro and 665 con sign-ins, and the remaining two agenda bills were postponed to a later hearing.

Bills: HB117, HB17, HB22, HB153, HB140, HB117, HB17, HB22, HB153, HB140, SB12, SB42, SB93, SB28, SB35, SB134, SB12, SB42, SB93, SB28, SB35, SB134

Keywords: procurement, county commission, administrative savings, public services, government efficiency, HB17, municipal audits, municipal audit clarification act, municipal finance, local government, city council, mayor, city manager, Department of Examiners of Public Accounts, independent public accountant, annual audit, biennial audit, annual report, financial accountability, public records

Transcript Highlights:

• The drug price we use is the same drug price that the federal government has released.
• The drug price we use is the same drug price that the federal government has released, so the national
• Where did the prices for drugs start? Who sets those?
• the price of the drug starts?
• I work to unravel drug pricing riddles for a living.

Bills: SB511, SB512, HB591, HB909, HB938, HB1154, HB1187

Keywords: automobile repairs, insurance transparency, repair shop liability, non-OEM parts, policyholder rights, automobile insurance, appraisal process, insurance policyholders, dispute resolution, claim valuation, family leave, insurance, paid leave, employment benefits, caregiver support, behavioral health, crisis services, mental health care, insurance coverage, healthcare access

Transcript Highlights:

• , acquisition price?
• House Bill 2145 is the bill relating to the 340B program.
• costs, payment amounts received for 340B drugs, payments made to pharmacies and other entities, how
• for 340B drugs.
• , overcharges, and average 340B discounts.

Bills: HB2384, HB2402, HB2505, HB1904, HB2145, HB2182, HB2211, HB2242, HB2247, HB2329, HB2339

Keywords: continuing care retirement community, CCRC, life plan community, senior housing, retirement community, long-term care, assisted living, nursing home, actuarial analysis, solvency, financial oversight, resident contracts, entrance fee, disclosure statement, registration, insurance commissioner, DSHS, consumer protection, elder care, aging services

Summary: The committee held public hearings on three bills. HB 2384 would require continuing care retirement communities that offer life care contracts to submit actuarial analyses every other registration cycle for review by the Office of the Insurance Commissioner, with results sent to DSHS for registration decisions and an appeal process through DSHS. Supporters said the bill would improve transparency and protect residents’ financial security; LeadingAge Washington supported transparency but raised cost and implementation concerns. HB 2505 would exempt certain foster parents and child-specific foster care providers from adult family home licensure when former foster youth remain in the home as adults and other conditions are met. The sponsor and DSHS said the bill would help vulnerable young adults stay with caregivers and avoid unnecessary licensure barriers. HB 2402 would phase out DEHP in IV solution containers and later IV tubing, with exemptions for certain blood and cell therapy products; testimony largely supported removing phthalates for health and environmental reasons, while manufacturers, hospitals, and AdvaMed raised supply chain, timing, and implementation concerns and requested later phase-out dates and exemptions. In executive session, the committee adopted amendments and advanced several bills. HB 1904, prohibiting cat declawing, was amended to remove recordkeeping, reporting, fines, and disciplinary references tied to declawing and was reported out with a do pass recommendation. HB 2145 on the 340B drug pricing program was advanced as a proposed substitute after a lengthy discussion about transparency, reporting, and concerns over authority and litigation. HB 2182, concerning abortion medications held and distributed by the Department of Corrections, was amended to require appropriations for purchases, restore cost-based distribution language, prioritize Indian health providers, add annual reporting, and remove the emergency clause; the substitute bill then passed out of committee. HB 2211 on medically tailored meals also passed out, with one member opposing due to concerns about limiting participation to certain nonprofits. The committee also passed out HB 2247 on veterinarian-client-patient relationships and telehealth after adopting a substitute that clarified recordkeeping, telehealth prescribing, clinical practice requirements, and the effective date. HB 2329 on supervision of medical assistants and lactation consultants by licensed midwives passed after a cleanup amendment clarified that midwives are not prohibited from coordinating with lactation consultants. HB 2339 on nurse licensing passed after a technical amendment updated definitions and terminology for nurse practitioner and clinical nurse specialist credentials. The meeting concluded with all of these measures reported from committee, mostly on strong bipartisan votes, though several bills drew mixed votes or dissent over scope, costs, or implementation.

Transcript Highlights:

• for a drug is lower than the price under their insurance plan.
• drugs is.
• Inflation has caused drug prices to increase, and patients are paying sometimes three and a half times
• Rising drug prices have forced many Texans to choose between their medications and other essential expenses
• We think this is a great way to encourage competition and get price transparency out there in the drug

Bills: SB95, SB268, SB493, SB619, SB660, SB922, SB984, SB1098, SB1188, SB1307, SB1332, SB1822

Keywords: immunization, written informed consent, civil liability, health care provider, vaccine compensation, administrative penalty, health care, licensing, complaint procedure, disciplinary action, law enforcement, pharmacy benefit manager, PBM, gag clause, prescription drug pricing, out-of-pocket cost, cash price, pharmacist, pharmacy, prescription drug benefit

Bills: SB115, SB131, SB93, HB319, HB163, HB268, SB115, SB131, SB93, HB319, HB163, HB268, HB181, HB153, SB132, SB26, SB189, SB196, HB140, SB197, HB117

Keywords: SB115, Alabama, impersonating a peace officer, peace officer, law enforcement impersonation, police impersonation, unauthorized police officer, fake cop, certification revoked, certification suspended, Alabama Peace Officers' Standards and Training Commission, APOSTC, Class C felony, law enforcement hiring, appointment of officers, federal law enforcement, arrest authority, public order, criminal offenses, Judiciary Committee

Transcript Highlights:

• Cannot administer drugs at all. No, any other questions on the bill?
• A congressional House Judiciary study shows that these vertically integrated companies increase drug
• prices.
• But the hospital Kept all the liability for those drugs.
• Does this allow does does this allow my local pharmacist to Prescribe drugs or deliver drugs that heretofore

Bills: HB3552, HB2984, HB4124, HB3934, HB3448, HB3131, HB4200, HB4201, HB3011, HB1912, HB3380, HB3881, HB3538, HB3851, HB3907, HB4430, HB4431, HB4457

Keywords: childcare, differential pricing, Department of Human Services, child care subsidy, licensed providers, emergency legislation, child care, subsidy program, annual report, program integrity, overpayments, ivermectin, over-the-counter medication, pharmacy immunity, healthcare access, FDA approval, prescription, public health, dentistry, licensing

Transcript Highlights:

• prices.
• a session and say, hey, look, see what those independent pharmacists did and see how they raised prices
• , so hospitals couldn’t make the margin on the drugs that the PBMs would make them and send them to the
• Does this allow my local pharmacist to prescribe drugs or deliver drugs that here before that... ...prescribe
• drugs or deliver drugs that here before they've been unable to because of certain terms and conditions

Bills: HB3552, HB2984, HB4124, HB3934, HB3448, HB3131, HB4200, HB4201, HB3011, HB1912, HB3380, HB3881, HB3538, HB3851, HB3907, HB4430, HB4431, HB4457

Keywords: childcare, differential pricing, Department of Human Services, child care subsidy, licensed providers, emergency legislation, child care, subsidy program, annual report, program integrity, overpayments, ivermectin, over-the-counter medication, pharmacy immunity, healthcare access, FDA approval, prescription, public health, dentistry, licensing

Summary: The committee took up a series of health, human services, and related bills. House Bill 3552, allowing child care providers to bridge the gap between subsidy reimbursement rates and standard tuition rates, was adopted and reported out 11-2. House Bill 2984, as a substitute, would direct DHS to compile a report on the child care system, including subsidy payment error rates, the number of facilities, closures, and voluntary closure feedback; it was reported out 14-0. House Bill 4201, changing master teacher requirements in child care from licensed capacity to actual enrollment, also passed unanimously. House Bill 3380, creating the Fostering the Future for Oklahoma Children and Families Act to modernize foster care data systems and improve outcomes, passed 12-0. House Bill 4430 and House Bill 4431, both cleanup measures tied to prior nurse practitioner/PA scope and pharmacy-related provisions, each passed 13-0. Several bills focused on health care access, regulation, and public safety. House Bill 4124 would allow over-the-counter ivermectin sales for human use with labeling and dosing information; after extensive questioning about safety, labeling, children, and liability, it passed 9-5. House Bill 3934, a large amended measure affecting dental practice and supervision rules, passed 14-0 after discussion about x-rays, telemedicine, and dental assistants. House Bill 3448, requiring insurance coverage related to group home provider liability for property damage, passed 14-0. House Bill 3131, setting baseline standards and oversight for homeless shelters with roles split between Commerce and Health, drew concerns about local control, temporary shelters, and fiscal impact, but passed 8-6. House Bill 4200, creating a revolving fund for forensic assertive community treatment teams to address the jail-to-homelessness cycle for people with severe mental illness, passed 11-3. The committee also advanced several public health, consumer, and industry bills. House Bill 1912, the Corn Masa Nutrition Enhancement Act, generated extensive debate over folic acid fortification, parental choice, MTHFR genetics, and potential health effects; with a PCS allowing a non-fortified option, it passed 9-5. House Bill 3011 repealed the home brewing license while keeping home-brewing limits and sales restrictions, and passed 11-3. House Bill 3881, the Alternative Nicotine Products Regulatory Act, increased application costs and removed a registry deemed inconsistent with federal law, passing 13-0. House Bill 3538, targeting pharmacy benefit manager vertical integration and its effects on access and pricing, passed 13-0 after discussion of mail-order restrictions and pharmacy closures. House Bill 3851, defining private label/control label alcoholic beverages under the three-tier system, also passed 13-0. House Bill 3907, requiring direct-hire staffing for facilities serving vulnerable adults and children with a short temporary staffing grace period, passed 13-0. The committee then moved on to House Bill 4457, a specialty-drug/PBM measure, with discussion beginning about PBM practices and specialty pharmacy access.

Transcript Highlights:

• So if tariffs are already pushing that price up, then requiring businesses to keep up with every new
• So if tariffs are already pushing that price up, then requiring businesses to keep up with every new
• There have been a number of factors that have driven up the price of cars over the last 10 years.
• There have been a number of factors that have driven up the price of cars over the last 10 years.
• Because we don't even make the cars, we're at the mercy of what the manufacturers have to say is the price

Bills: H5036, H5138

Keywords: tariff transparency, consumer disclosure, price transparency, vehicle pricing, Monroney label, auto dealer, car manufacturer, retail pricing, shelf tag, receipt disclosure, online storefront, import duties, trade taxes, Chapter 93A, Attorney General enforcement, consumer protection, federal preemption, customs, supply chain costs, tariff surcharge

Transcript Highlights:

• So it's straightforward pricing, consumer protection. With that, I move a due pass.
• We've seen over the years, the last 10 years, that our prices have skyrocketed.
• The prices are... ...rocketed. If you look at the scale, it's almost vertical.
• The prices have gone up and up and up, and that's our problem.
• If PBMs claim they save money, but yet drug costs and premiums keep rising, at this point in time, I

Bills: SB1673, SB1500, SB1447, SB1646, SB2007, SB1275, SB2074

Keywords: prosthetics, health insurance, medical necessity, patient rights, insurance liability, pharmacy benefits manager, healthcare providers, claims processing, reimbursement, insurance regulation, employees insurance, contract awarding, certifications, state procurement, insurance plan, mental health, substance use disorders, utilization review, benefit coverage, pharmacy

Summary: The Senate Business and Insurance Committee met to consider several bills, with the chair emphasizing pharmacy benefit managers (PBMs) and the impact on local and rural pharmacies. Before taking up the bills, the committee announced that Senate Bills 1620 and 1625 would be laid over. The committee also adopted an amendment to Senate Bill 1673 to exempt certain state-funded flexible benefit plans, and then passed the bill, which creates the Prosthetic Access and Accountability Act of 2026 and requires health plans that already cover prosthetic benefits to administer them without disability-based discrimination. The committee then passed several PBM-related measures. Senate Bill 1500 requires PBMs to reimburse rural pharmacies within 30 calendar days. Senate Bill 1447 adds safeguards to the Oklahoma Employee Insurance Plan by restricting PBM contracts, including disfavoring PBMs involved in recent lawsuits or those affiliated with insurers, retail pharmacy chains, specialty pharmacies, mail-order pharmacies, or drug manufacturers. Senate Bill 1646 strengthens utilization review standards for mental health and substance use disorder treatment, and Senate Bill 2007 prohibits PBMs from reducing reimbursement after a successful appeal and adds administrative fees when they fail to make required adjustments. The committee also passed Senate Bill 1275, which requires upfront disclosure of all fees for short-term rental bookings such as Airbnb and VRBO, with only tax added at checkout. Finally, the committee passed Senate Bill 2074 after extensive debate; it would require fairer and more transparent PBM reimbursement using a Medicaid-based methodology and a professional dispensing fee, with supporters arguing it would help independent and community pharmacies and opponents raising concerns about consumer costs and legal issues. All bills considered in the meeting were reported out with favorable votes, and the meeting adjourned after the chair noted one more meeting would be held the following week.

Transcript Highlights:

• Currently, pharmacies are able to obtain the best pricing from wholesalers by having their accounts drafted
• We've seen over the years, the last 10 years, that our prices have skyrocketed.
• The prices have gone up and up and up, and that's our problem.
• If PBMs claim they save money but yet drug costs and premiums keep rising.
• If they say it will cost consumers' prices to go up, it's because they choose it for no other reason.

Bills: SB1673, SB1500, SB1447, SB1646, SB2007, SB1275, SB2074

Keywords: prosthetics, health insurance, medical necessity, patient rights, insurance liability, pharmacy benefits manager, healthcare providers, claims processing, reimbursement, insurance regulation, employees insurance, contract awarding, certifications, state procurement, insurance plan, mental health, substance use disorders, utilization review, benefit coverage, pharmacy

Transcript Highlights:

• This is like hospital pricing.
• Medicaid, a high price schedule, a low price schedule; pricing varies in network, out of network, and
• </c> price schedules.
• Medicaid a high price price schedules.
• </c><00:58:54.799><c> schedule</c><00:58:55.280><c> pricing</c> schedule a low price schedule pricing

Bills: SF0023, SF0057

Keywords: mental health, involuntary hospitalization, examiners, public safety, Wyoming legislature, hospital pricing, healthcare transparency, public health, civil penalties, shoppable services, 916, all

Bills: SF0023, SF0057

Keywords: mental health, involuntary hospitalization, examiners, public safety, Wyoming legislature, hospital pricing, healthcare transparency, public health, civil penalties, shoppable services, 916, all

Transcript Highlights:

• One, it says that if a drug that is covered by an insurance company already is available at a lower price
• The companies will lower the price of their drug in order to get covered.
• The companies will lower the price of their drug in order to get covered.
• But that would be a guardrail that allows us to truly say that the lowest-cost drug, the net price of
• And the way it works is every drug out there, the high-cost specialty drugs, has priced in it a manufacturer

Bills: HB591, HB765, HB826, HB870, HB938, HB1151, HB1162, HB1176, HB1196, HB1236, HB1241

Keywords: family leave, insurance, paid leave, employment benefits, caregiver support, liability insurance, coverage defenses, direct action, judgment enforcement, legal procedures, insurance referrals, compensation, non-licensed agents, consumer protection, insurance products, HB 870, Act 907, Louisiana insurance, health insurance, prescription drugs

Transcript Highlights:

• Americans to drug poisonings, primarily due to illicit fentanyl flooding across our borders.
• They're involved in drugs, fentanyl. Extortion, kidnapping, drugs, intimidation, money laundering.
• I'm claiming that... ...in terms of drug dealing? Sorry to interrupt you, sir.
• How does this diversion of resources help us fight drugs in our communities?
• And so many times violent crime is tied to drug trafficking.

Keywords: fentanyl crisis, DEA, drug trafficking, public safety, Judea Serrata, Terrence Cole, judicial security, social media, drug prevention

Summary: The committee meeting centered on the urgent crisis of fentanyl abuse and the government’s response to the drug trafficking epidemic. Key discussions revolved around the nomination of Terrence Cole as the Administrator of the DEA and Judea Serrata as Director of the U.S. Marshals Service. Cole emphasized his commitment to combating the fentanyl crisis, highlighting the rising number of overdose deaths and the necessity of bipartisan efforts to dismantle drug cartels. Members engaged in dialogue on the effectiveness of various strategies and the importance of education aimed at preventing drug-related deaths among youth. Additionally, the challenges of social media in drug trafficking were highlighted, indicating a need for greater accountability in how platforms handle such issues. Senators voiced concerns about the impact of administration policies on judicial security and the resources available for marshals to perform their critical roles.